Literature DB >> 24516030

Successful treatment with dabrafenib (GSK2118436) in a patient with ganglioglioma.

Kent C Shih1, Mythili Shastry2, Jeffrey T Williams3, Peter F Jelsma3, Steven R Abram3, Kanyalakshmi Ayyanar4, Howard A Burris5, Jeffrey R Infante5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24516030     DOI： 10.1200/JCO.2013.48.6852

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  7 in total

1.  Suprasellar ganglioglioma presenting as a middle cerebral artery infarction.

Authors:  Laura Pastor; Sara Iglesias; Bienvenido Ros; Bernardo Weil; María Isabel Martínez-León; Miguel Ángel Arráez
Journal:  Childs Nerv Syst       Date:  2019-07-09       Impact factor: 1.475

2.  Efficacy of Dabrafenib for three children with brainstem BRAFV600E positive ganglioglioma.

Authors:  Laflamme Philippe; Kondyli Maria; Aljared Tariq; Miconiatis Sofia; Saint-Martin Christine; Farmer Jean-Pierre; Roy W Dudley; Perreault Sébastien; Jabado Nada; Larouche Valérie
Journal:  J Neurooncol       Date:  2019-09-09       Impact factor: 4.130

3.  PD-L1 Expression in Pediatric Low-Grade Gliomas Is Independent of BRAF V600E Mutational Status.

Authors:  Allison M Martin; W Robert Bell; Ming Yuan; Lauren Harris; Bradley Poore; Antje Arnold; Elizabeth L Engle; Laura Asnaghi; Michael Lim; Eric H Raabe; Charles G Eberhart
Journal:  J Neuropathol Exp Neurol       Date:  2020-01-01       Impact factor: 3.148

4.  Dabrafenib in patients with recurrent, BRAF V600E mutated malignant glioma and leptomeningeal disease.

Authors:  Michael C Burger; Michael W Ronellenfitsch; Nadja I Lorenz; Marlies Wagner; Martin Voss; David Capper; Theophilos Tzaridis; Ulrich Herrlinger; Joachim P Steinbach; Gabriele Stoffels; Karl-Josef Langen; Christian Brandts; Christian Senft; Patrick N Harter; Oliver Bähr
Journal:  Oncol Rep       Date:  2017-10-02       Impact factor: 3.906

5.  Adult pilocytic astrocytoma in the molecular era: a comprehensive review.

Authors:  Timothy A Gregory; Lyndon B Chumbley; John W Henson; Brett J Theeler
Journal:  CNS Oncol       Date:  2021-01-15

6.  Treatment of BRAF V600E mutated ganglioglioma of the third ventricle with dabrafenib.

Authors:  Ethan John Kilmister; Bridget Robinson; Claudio De Tommasi
Journal:  Surg Neurol Int       Date:  2021-10-19

7.  Targetable BRAF and RAF1 Alterations in Advanced Pediatric Cancers.

Authors:  Andrew Rankin; Adrienne Johnson; Alison Roos; Geoffrey Kannan; Jeffrey Knipstein; Nicholas Britt; Mark Rosenzweig; James Haberberger; Dean Pavlick; Eric Severson; Jo-Anne Vergilio; Rachel Squillace; Rachel Erlich; Pratheesh Sathyan; Stuart Cramer; David Kram; Jeffrey Ross; Vince Miller; Prasanth Reddy; Brian Alexander; Siraj M Ali; Shakti Ramkissoon
Journal:  Oncologist       Date:  2020-09-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.